1. Home
  2. AVNW vs TNXP Comparison

AVNW vs TNXP Comparison

Compare AVNW & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVNW
  • TNXP
  • Stock Information
  • Founded
  • AVNW 2006
  • TNXP 2007
  • Country
  • AVNW United States
  • TNXP United States
  • Employees
  • AVNW N/A
  • TNXP N/A
  • Industry
  • AVNW Radio And Television Broadcasting And Communications Equipment
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • AVNW Technology
  • TNXP Health Care
  • Exchange
  • AVNW Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • AVNW 291.3M
  • TNXP 335.6M
  • IPO Year
  • AVNW 2007
  • TNXP N/A
  • Fundamental
  • Price
  • AVNW $22.83
  • TNXP $61.57
  • Analyst Decision
  • AVNW Strong Buy
  • TNXP Buy
  • Analyst Count
  • AVNW 5
  • TNXP 1
  • Target Price
  • AVNW $37.60
  • TNXP $70.00
  • AVG Volume (30 Days)
  • AVNW 81.1K
  • TNXP 1.7M
  • Earning Date
  • AVNW 10-03-2025
  • TNXP 08-11-2025
  • Dividend Yield
  • AVNW N/A
  • TNXP N/A
  • EPS Growth
  • AVNW N/A
  • TNXP N/A
  • EPS
  • AVNW N/A
  • TNXP N/A
  • Revenue
  • AVNW $435,926,000.00
  • TNXP $9,831,000.00
  • Revenue This Year
  • AVNW $8.50
  • TNXP $22.87
  • Revenue Next Year
  • AVNW $5.18
  • TNXP $711.66
  • P/E Ratio
  • AVNW N/A
  • TNXP N/A
  • Revenue Growth
  • AVNW 14.58
  • TNXP N/A
  • 52 Week Low
  • AVNW $12.96
  • TNXP $6.76
  • 52 Week High
  • AVNW $28.37
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • AVNW 53.16
  • TNXP 72.07
  • Support Level
  • AVNW $20.81
  • TNXP $42.12
  • Resistance Level
  • AVNW $22.08
  • TNXP $48.50
  • Average True Range (ATR)
  • AVNW 0.76
  • TNXP 5.40
  • MACD
  • AVNW 0.04
  • TNXP 1.38
  • Stochastic Oscillator
  • AVNW 69.68
  • TNXP 91.43

About AVNW Aviat Networks Inc.

Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: